Search | OpenScholar

Search results

755 results found

Early Renal Denervation Attenuates Cardiorenal Dysfunction in Heart Failure with Preserved Ejection Fraction

Publication: Journal Article

Doiron, JE., Z. Li, TE. Sharp, KB. LaPenna, K. Koul, AJ. Malek, SJ. Shah, et al. 2024. “Early Renal Denervation Attenuates Cardiorenal Dysfunction in Heart Failure With Preserved Ejection Fraction”. Journal of the American Heart Association.

Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure

Publication: Journal Article

Li, Z., H. Xia, TE. Sharp, KB. LaPenna, JW. Elrod, JW. Calvert, FN. Salloumn, et al. 2022. “Mitochondrial H2S Regulates BCAA Catabolism in Heart Failure”. Circulation Research.

Adjunctive Therapy with an Oral H2S Donor Provides Additional Therapeutic Benefit Beyond SGLT2 Inhibition in Cardiometabolic HFpEF

Publication: Journal Article

Doiron, JE., H. Xio, X. Yu, AR. Nevins, KB. LaPenna, TE. Sharp, TT. Goodchild, et al. 2024. “Adjunctive Therapy With an Oral H2S Donor Provides Additional Therapeutic Benefit Beyond SGLT2 Inhibition in Cardiometabolic HFpEF”. British Journal of Pharmacology.

Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®). Parkinsonism Relat Disord 2021;82:133-137.

Publication: Journal Article

Hauser, RA, L Zeitlin, S Fisher, and R D’Souza. 2021. “Duration of Benefit Per Dose: Carbidopa-Levodopa Immediate Release Vs. Extended Release Capsules (Rytary®). Parkinsonism Relat Disord 2021;82:133-137.”. Parkonsonism Relat Disord.

Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.

Publication: Journal Article

Patel, AT, MF Lew, K Dashtipour, S Isaacson, RA Hauser, W Ondo, P Maisonobe, S Wietek, B Rubin, and A Brashear. 2021. “Sustained Functional Benefits After a Single Set of Injections With AbobotulinumtoxinA Using a 2-ML Injection Volume in Adults With Cervical Dystonia: 12-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3b Study.”. ECollection.

Study Investigators. Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary? 2023 Mar 22. doi: 10.3233/JPD-223537. 2023;13(3):403-414. PMID: 36970914

Publication: Journal Article

Hauser, RA, WG Ondo, L Zhang, A Bowling, B Navia, E Pappert, and SH Isaacson. 2023. “Study Investigators. Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary? 2023 Mar 22. Doi: 10.3233/JPD-223537. 2023;13(3):403-414. PMID: 36970914”. J Parkinsons Dis.

Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search. Parkinsons Dis. 2022 Jun 7;2022:2920255. doi: 10.1155/2022/2920255. eCollection 2022. PMID: 35711334

Publication: Journal Article

Morinan, G, RA Hauser, A Schrag, J Tang, J O’Keeffe, and MDS-NMS Scale Development Study Group. 2022. “Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search. Parkinsons Dis. 2022 Jun 7;2022:2920255. Doi: 10.1155/2022/2920255. ECollection 2022. PMID: 35711334”. Parkinsons Dis.

Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder. Brain, 143(8), 2437–2453. https://doi.org/10.1093/brain/awaa204

Publication: Journal Article

“Biallelic MADD Variants Cause a Phenotypic Spectrum Ranging from Developmental Delay to a Multisystem Disorder. Brain, 143(8), 2437–2453. Https://Doi.org/10.1093/Brain/Awaa204”. 2020. Brain.

Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease. Mov Disord Clin Pract 2018;5:627-634.

Publication: Journal Article

Hauser, RA, I Biaggioni, LA Hewitt, and S Vernino. 2018. “Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson Disease. Mov Disord Clin Pract 2018;5:627-634.”. Mov Disord Clin Pract.

NINDS NET-PD Investigators. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1. J Parkinsons Dis 2017;7:117-127.

Publication: Journal Article

Hauser, RA, R Li, A Perez, X Ren, D Weintraub, J Elm, JL Goudreau, et al. 2017. “NINDS NET-PD Investigators. Longer Duration of MAO-B Inhibitor Exposure Is Associated With Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1. J Parkinsons Dis 2017;7:117-127.”. J Parkinsons Dis.